Filing Details

Accession Number:
0001127602-16-062825
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-19 17:06:04
Reporting Period:
2016-09-15
Filing Date:
2016-09-19
Accepted Time:
2016-09-19 17:06:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298823 J Kendall Powell General Mills
One General Mills Blvd
Minneapolis MN 55426
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2016-09-15 2,977 $51.61 27,198 No 4 M Direct
Ordinary Shares Acquisiton 2016-09-15 1,010 $52.84 28,208 No 4 M Direct
Ordinary Shares Acquisiton 2016-09-15 1,590 $50.34 29,798 No 4 M Direct
Ordinary Shares Acquisiton 2016-09-15 2,671 $29.96 32,469 No 4 M Direct
Ordinary Shares Acquisiton 2016-09-15 1,813 $44.13 34,282 No 4 M Direct
Ordinary Shares Disposition 2016-09-15 7,907 $85.45 26,375 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2016-09-15 2,977 $0.00 2,977 $51.61
Ordinary Shares Stock Option (Right to Buy) Disposition 2016-09-15 1,010 $0.00 1,010 $52.84
Ordinary Shares Stock Option (Right to Buy) Disposition 2016-09-15 1,590 $0.00 1,590 $50.34
Ordinary Shares Stock Option (Right to Buy) Disposition 2016-09-15 2,671 $0.00 2,671 $29.96
Ordinary Shares Stock Option (Right to Buy) Disposition 2016-09-15 1,813 $0.00 1,813 $44.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-06-22 No 4 M Direct
0 2017-09-01 No 4 M Direct
0 2018-04-28 No 4 M Direct
0 2019-04-27 No 4 M Direct
0 2020-05-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 3,000 Indirect By Spouse Revocable Trust
Footnotes
  1. This balance increased by 110 shares due to exempt transactions such as dividend reinvestment.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.433 to $85.453, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. This option to purchase 2,713 New Medtronic ordinary shares for $51.61 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,713 Medtronic common stock shares for $51.61 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  4. This option to purchase 264 New Medtronic ordinary shares for $51.61 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 264 Medtronic common stock shares for $51.61 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  5. This option to purchase 1,010 New Medtronic ordinary shares for $52.84 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,010 Medtronic common stock shares for $52.84 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  6. This option to purchase 1,590 New Medtronic ordinary shares for $50.34 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,590 Medtronic common stock shares for $50.34 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  7. This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  8. This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.